RADCOM Ltd. — Form 20-F Summary
Reporting period: Fiscal year ended December 31, 2012; filed April 22, 2013. This is an annual report, not a standalone fourth-quarter filing, so Q4-specific financial results are not clearly provided. Figures below are in U.S. dollars unless stated otherwise; financial statements use U.S. GAAP.
Business context
RADCOM provides service-assurance and network-monitoring solutions to communications service providers and equipment vendors. Its principal product family is Omni-Q. Revenue is concentrated in relatively few, often large orders, and customer acceptance and deployment requirements can delay revenue recognition—typically 9–18 months for larger deals.
Key financial metrics
| Metric | FY 2012 | FY 2011 |
|---|---|---|
| Revenue | $15.786 million | $21.987 million |
| Gross profit / margin | $9.604 million / 60.8% | $15.307 million / 69.6% |
| Operating income (loss) | $(5.553) million | $(1.520) million |
| Net income (loss) | $(5.987) million | $(1.904) million |
| Net loss per share | $(0.93) | $(0.30) |
| Cash flow from operations | $(2.461) million | $(3.350) million |
| Cash and cash equivalents at year-end | $1.474 million | $2.901 million |
| Working capital | $5.194 million | $10.670 million |
| Total assets / shareholders’ equity | $18.997 million / $4.997 million | $21.345 million / $10.392 million |
At December 31, 2012, the balance sheet reported $1.058 million of short-term bank credit and $1.527 million of short-term loans, including $777,000 from Chairman and major shareholder Zohar Zisapel. Restricted cash was $1.452 million, largely securing customer-related guarantees. Operating cash burn improved year over year, although cash declined and equity fell substantially.
Changes versus prior year
- Revenue fell 28%, reflecting telecom-sector spending weakness, especially in the first half, and delayed recognition of larger, more complex projects. Omni-Q revenue declined about 27%; Performer and other revenue declined about 45%.
- Gross margin contracted to 60.8% from 69.6%, as lower revenue was spread across fixed costs.
- Operating expenses fell about 10% to $15.157 million, mainly from sales and marketing reductions, but remained high relative to revenue. Gross R&D spending rose to $6.102 million from $5.866 million.
- Services revenue increased to $3.306 million from $2.788 million, partly reflecting growth in warranty services; product revenue decreased to $12.480 million from $19.199 million.
- Revenue mix shifted geographically: Europe and Brazil declined, while North America and South America excluding Brazil increased. No customer exceeded 10% of revenue in 2012.
Outlook, risks and unusual items
- Management reported improved telecom-market conditions in the second half of 2012 and expected continued market growth in 2013 and beyond. It anticipated 2013 profitability, but this was a forward-looking expectation, not a guarantee.
- Management believed available capital and operating cash flows could meet expected needs through December 2013, based partly on backlog and pipeline. It also said it might seek additional financing; there is no assurance of availability or adequate liquidity beyond that period.
- The company breached a bank covenant requiring shareholders’ equity to be at least 32% of total assets at year-end. The bank allowed a cure period through July 15, 2013; failure to cure could trigger repayment of the $1.5 million facility. The facility is secured by a first-priority charge over company assets. Management cited expected profitability, a possible further bank extension and advanced private-placement discussions as potential remedies, none assured.
- The shareholder loan was interest-free but CPI-linked, originally due March 31, 2013; repayment was extended to June 30, 2013. The filing states the amount owed was NIS 2.893 million as of April 19, 2013.
- The company disclosed approximately $33.5 million of contingent royalty obligations to Israel’s Office of the Chief Scientist, payable from qualifying product revenues. The agency had raised alleged royalty-calculation differences for 1992–2009; RADCOM believed amounts were paid or accrued but could not assess the agency’s claims. A further approximately $348,000 contingent BIRD Foundation royalty obligation was disclosed.
- Other material risks include prolonged customer sales and acceptance cycles, customer spending cuts, distributor reliance, component and contract-manufacturer concentration, inventory obsolescence, foreign-exchange exposure, and competition. The company reported no off-balance-sheet arrangements and no legal proceedings; management assessed internal control over financial reporting as effective.
Important facts for investors to verify
- Whether RADCOM cured the bank covenant breach by the deadline, and whether the bank facility and related guarantees were renewed or repaid.
- Whether the expected 2013 profitability and liquidity outlook materialized, including any subsequent financing or private placement.
- Progress in deploying and obtaining customer acceptance for large deals, and conversion of backlog into recognized revenue and cash collections.
- Resolution and potential financial impact of the Chief Scientist royalty review, and the terms and remaining balance of royalty obligations.
- Subsequent trends in revenue, gross margin, cash burn, working capital, restricted cash and short-term borrowing.